Bank of America dropped its target price on Tandem Diabetes Care, while TD Cowen reissued a buy rating for the company.

The entities involved

• Tandem Diabetes Care, Inc. →

  U.S. healthcare company

  • Tandem Mobi utilizes Dexcom G7 technology for monitoring.Mon 09:18
  • Solventum and Tandem Diabetes Care, Inc., two companies in the healthcare sector, are currently facing market comparison.Sun 18:43
• Bank of America →

  American multinational banking and financial services corporation

  • Goldman Sachs, Morgan Stanley, JPMorgan Chase, and Bank of America are competing in the global investment banking sector.Mon 17:24
  • Both Bank of America and Deloitte have addressed current treasury management trends.Mon 14:26
• TD Cowen →

  American investment bank

  • Analyst downgraded Ag Growth International Inc. due to debt management risks.Mon 12:33
  • TD Cowen raised its price target and gave a buy rating for Travere Therapeutics, Inc., while various institutional investors bought into the company.Mon 10:36

Related events

• TD Cowen, Jefferies, and Citigroup issued updated ratings and target prices for Procore Technologies, Inc.Aug 30
• Bank of America, TD Cowen, and Norges Bank announced new actions regarding T-Mobile US shares.Aug 27
• Truist Financial and TD Cowen raised target prices and issued buy ratings for Astrana Health, Inc. on June 10, 2026.Jun 10
• TD Cowen lowered its price target on Paychex, while S&P Global Market Intelligence reported a stock decline.Fri 22:09
• Bank of America boosted its price target and gave a buy rating for Guardian Pharmacy Services, Inc. on September 15, 2026. Truist Financial also boosted its target price and gave a buy rating on the same day.Sep 15